Corvus Pharmaceuticals' Series B Round

Corvus Pharmaceuticals raised a round of funding on September 25, 2015.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomp…

Articles about Corvus Pharmaceuticals' Series B Round: